Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
10
Recruiting, any sponsor type, condition "Huntington"
By trial status
The same filters, counted in each status. Pick one to switch.
10 trials
Showing 1 to 10, recently updated first.
- Pridopidine Phase 3 Study in Huntington's DiseasePivotal-lookingRecruiting
PrileniaIndustry
NCT07609108 · 400 participants (planned) · Start Jul 1, 2026 · Primary completion Jun 2028
Drug: Pridopidine; Placebo · For: Huntington Disease
Sites: Birmingham, Alabama; La Jolla, California; Los Angeles, California · 66 sites in all
- A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's DiseaseRecruiting
Sarepta Therapeutics, Inc.Industry
NCT07536061 · 32 participants (planned) · Start May 12, 2026 · Primary completion Nov 30, 2027
Drug: SRP-1005; Placebo · For: Huntington's Disease
Sites: Westmead, Australia; Parkville, Australia; Christchurch, New Zealand · 8 sites in all
Alnylam PharmaceuticalsAlnylam Pharmaceuticals (ALNY)
NCT06585449 · 66 participants (planned) · Start Oct 14, 2024 · Primary completion Jul 5, 2028
Drug: ALN-HTT02; Placebo · For: Huntington's Disease
Sites: Edmonton, Canada; Montreal, Canada; Ottawa, Canada · 19 sites in all
- Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's DiseasePivotal-lookingRecruiting
Skyhawk Therapeutics, Inc.Industry
NCT07378644 · 400 participants (planned) · Start Jan 6, 2026 · Primary completion Dec 2028
Drug: SKY-0515; SKY-0515 Placebo · For: Huntington Disease
Sites: Englewood, Colorado; Boston, Massachusetts; Charlestown, Massachusetts · 31 sites in all
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT06147414 · 550 participants (planned) · Start Oct 23, 2024 · Primary completion May 2027
Drug: Blood sample · For: Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including; Sickle Cell Disease; Cystic Fibrosis and 12 more
Sites: Paris, France
- A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's DiseasePivotal-lookingRecruiting
Novartis PharmaceuticalsNovartis (NVS)
NCT07326709 · 770 participants (planned) · Start Mar 24, 2026 · Primary completion Apr 2, 2030
Drug: Votoplam (blinded); Placebo · For: Huntington Disease
Sites: Birmingham, Alabama; Little Rock, Arkansas; La Jolla, California · 117 sites in all
Vico Therapeutics B. V.Industry
NCT05822908 · 68 participants (planned) · Start Feb 14, 2023 · Primary completion Apr 1, 2028
Drug: VO659 · For: Spinocerebellar Ataxia Type 1; Spinocerebellar Ataxia Type 3; Huntington Disease
Sites: Copenhagen, Denmark; Angers, France; Montpellier, France · 14 sites in all
Leslie ThompsonAcademic, hospital or other
NCT07451613 · 21 participants (planned) · Start Apr 6, 2026 · Primary completion Jun 2028
Drug: hNSC-01 · For: Huntington Disease
Sites: Irvine, California
- A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion CarriersPivotal-lookingRecruiting
Western Sydney Local Health DistrictAcademic, hospital or other
NCT05509153 · 160 participants (planned) · Start Jun 1, 2024 · Primary completion Nov 1, 2026
Drug: NAC; Placebo · For: Huntington Disease
Sites: Westmead, Australia; Herston, Australia; Parkdale, Australia · 5 sites in all
Fundación Pública Andaluza para la gestión de la Investigación en SevillaAcademic, hospital or other
NCT04478734 · 24 participants (planned) · Start Apr 12, 2023 · Primary completion Jun 30, 2025
Drug: Moderate doses of Thiamine y Biotin; High doses of Thiamine y Biotin · For: Huntington Disease
Sites: San Sebastián, Spain; Seville, Spain; Madrid, Spain
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.